BARCLAYS PLC - IBERE PHARMACEUTICALS ownership

IBERE PHARMACEUTICALS's ticker is IBER and the CUSIP is G46843101. A total of 48 filers reported holding IBERE PHARMACEUTICALS in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of IBERE PHARMACEUTICALS
ValueSharesWeighting
Q3 2022$486,000
+1.0%
49,0230.0%0.00%
Q2 2022$481,00049,0230.00%
Other shareholders
IBERE PHARMACEUTICALS shareholders Q4 2022
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of IBERE PHARMACEUTICALS shareholders